XML 12 R1.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Document and Entity Information (USD $)
6 Months Ended
Jun. 30, 2011
Aug. 15, 2011
Document And Entity Information    
Entity Registrant Name FLUOROPHARMA MEDICAL, INC.  
Entity Central Index Key 0001402785  
Document Type 10-Q  
Document Period End Date Jun. 30, 2011
Amendment Flag true  
Amendment Description

FluoroPharma Medical, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (the “First Amendment”) to its Quarterly Report for the quarter ended June 30, 2011, which was filed with the Securities and Exchange Commission on August 15, 2011 (the “Form 10-Q”). This First Amendment is being file to include restated financials as of and for the period ended June 30, 2011 to reflect preferred stock dividends totaling $841,296 following the guidance of ASC 470-20. As a result of the restatement, the Company has revised its internal controls and procedures to disclose that they are not effective for the period covered by this report.

 

No other changes have been made to the Form 10-Q. This First Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q.

 
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Public Float   $ 20,903
Entity Common Stock, Shares Outstanding   20,902,653
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2011